Code | 4643C | ||||||||||
MA number | EU/1/16/1125/002 | ||||||||||
Product Form: | con inf 1x2,5 ml/25 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 28.04.2017 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 21.06.2021 |